CHMP anbefalede derfor, at der skulle gennemføres dosisfindingsundersøgelser for at fastslå, om behandling med 60 mg en gang dagligt også ville være passende hos nogle patienter.
The CHMP therefore recommended that dose finding studies should be explored to conclude if treatment with 60mg once daily would also be adequate for some patients.